Apple Watch Ultra 2 and Series 9 sales halted after release

Apple Watch sales for the latest Apple Watch Ultra 2 and Series 9 have been suspended due to patent infringement claims about the blood oxygen monitoring feature. The sales will cease on Apple's website starting December 21 and in Apple retail locations after December 24. This action comes after the International Trade Commission found in favor of medical technology company Masimo, who alleged that Apple infringed on their patents. Apple has confirmed its plans to appeal and explore all potential options to ensure their products are available to consumers. Given this, customers looking to purchase the new models might encounter difficulties for an indefinite period. Meanwhile, Apple has pledged to work towards getting these products back on the market as soon as possible.

Sales of the Apple Watch Ultra 2 and Series 9 are being halted due to a dispute with Masimo over alleged patent infringement related to the devices’ blood oxygen sensor technology.